Next-Generation and Single-Cell Sequencing Approaches to Study Atherosclerosis and Vascular Inflammation Pathophysiology: A Systematic Review.

atherosclerosis next-generation sequencing single-cell sequencing systematic review vascular inflammation

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 07 01 2022
accepted: 07 03 2022
entrez: 14 4 2022
pubmed: 15 4 2022
medline: 15 4 2022
Statut: epublish

Résumé

Atherosclerosis is a chronic inflammatory disease that remains the leading cause of morbidity and mortality worldwide. Despite decades of research into the development and progression of this disease, current management and treatment approaches remain unsatisfactory and further studies are required to understand the exact pathophysiology. This review aims to provide a comprehensive assessment of currently published data utilizing single-cell and next-generation sequencing techniques to identify key cellular and molecular contributions to atherosclerosis and vascular inflammation. Electronic searches of Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE databases were undertaken from inception until February 2022. A narrative synthesis of all included studies was performed for all included studies. Quality assessment and risk of bias analysis was evaluated using the ARRIVE and SYRCLE checklist tools. Thirty-four studies were eligible for narrative synthesis, with 16 articles utilizing single-cell exclusively, 10 utilizing next-generation sequencing and 8 using a combination of these approaches. Studies investigated numerous targets, ranging from exploratory tissue and plaque analysis, cell phenotype investigation and physiological/hemodynamic contributions to disease progression at both the single-cell and whole genome level. A significant area of focus was placed on smooth muscle cell, macrophage, and stem/progenitor contributions to disease, with little focus placed on contributions of other cell types including lymphocytes and endothelial cells. A significant level of heterogeneity exists in the outcomes from single-cell sequencing of similar samples, leading to inter-sample and inter-study variation. Single-cell and next-generation sequencing methodologies offer novel means of elucidating atherosclerosis with significantly higher resolution than previous methodologies. These approaches also show significant potential for translatability into other vascular disease states, by facilitating cell-specific gene expression profiles between disease states. Implementation of these technologies may offer novel approaches to understanding the disease pathophysiology and improving disease prevention, management, and treatment.

Sections du résumé

Background and Aims UNASSIGNED
Atherosclerosis is a chronic inflammatory disease that remains the leading cause of morbidity and mortality worldwide. Despite decades of research into the development and progression of this disease, current management and treatment approaches remain unsatisfactory and further studies are required to understand the exact pathophysiology. This review aims to provide a comprehensive assessment of currently published data utilizing single-cell and next-generation sequencing techniques to identify key cellular and molecular contributions to atherosclerosis and vascular inflammation.
Methods UNASSIGNED
Electronic searches of Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE databases were undertaken from inception until February 2022. A narrative synthesis of all included studies was performed for all included studies. Quality assessment and risk of bias analysis was evaluated using the ARRIVE and SYRCLE checklist tools.
Results UNASSIGNED
Thirty-four studies were eligible for narrative synthesis, with 16 articles utilizing single-cell exclusively, 10 utilizing next-generation sequencing and 8 using a combination of these approaches. Studies investigated numerous targets, ranging from exploratory tissue and plaque analysis, cell phenotype investigation and physiological/hemodynamic contributions to disease progression at both the single-cell and whole genome level. A significant area of focus was placed on smooth muscle cell, macrophage, and stem/progenitor contributions to disease, with little focus placed on contributions of other cell types including lymphocytes and endothelial cells. A significant level of heterogeneity exists in the outcomes from single-cell sequencing of similar samples, leading to inter-sample and inter-study variation.
Conclusions UNASSIGNED
Single-cell and next-generation sequencing methodologies offer novel means of elucidating atherosclerosis with significantly higher resolution than previous methodologies. These approaches also show significant potential for translatability into other vascular disease states, by facilitating cell-specific gene expression profiles between disease states. Implementation of these technologies may offer novel approaches to understanding the disease pathophysiology and improving disease prevention, management, and treatment.

Identifiants

pubmed: 35419441
doi: 10.3389/fcvm.2022.849675
pmc: PMC8996078
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

849675

Subventions

Organisme : British Heart Foundation
ID : PG/14/72/31080
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J015350/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T018208/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/66/33216
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/13/9/29990
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/16/61/32300
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/11/19/28827
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1992027/7163
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/17/46/33121
Pays : United Kingdom

Informations de copyright

Copyright © 2022 McQueen, Ladak, Abbasciano, George, Suleiman, Angelini, Murphy and Zakkar.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Circ Res. 2021 Oct;129(8):e146-e165
pubmed: 34474592
Cell Death Discov. 2021 Jul 16;7(1):180
pubmed: 34282126
Cardiovasc Res. 2012 Nov 1;96(2):234-43
pubmed: 22752349
BMC Genomics. 2022 Feb 26;23(1):163
pubmed: 35219290
Nat Methods. 2021 Jan;18(1):9-14
pubmed: 33408395
Circ Res. 2018 Oct 26;123(10):1127-1142
pubmed: 30359200
Science. 2016 Jul 1;353(6294):78-82
pubmed: 27365449
Circulation. 2020 Nov 24;142(21):2045-2059
pubmed: 32674599
Cells. 2022 Jan 25;11(3):
pubmed: 35159221
Circ Res. 2020 Jul 17;127(3):335-353
pubmed: 32336197
Front Genet. 2021 Nov 04;12:755507
pubmed: 34804124
J Cell Biol. 2015 Apr 13;209(1):13-22
pubmed: 25869663
Basic Res Cardiol. 2020 Jan 24;115(2):18
pubmed: 31980946
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Nat Med. 2019 Aug;25(8):1280-1289
pubmed: 31359001
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1293-H1303
pubmed: 30052471
Front Genet. 2019 May 07;10:426
pubmed: 31134132
Cleve Clin J Med. 2017 Dec;84(12 Suppl 4):e15-e19
pubmed: 29281607
Circ Res. 2018 Jun 8;122(12):1661-1674
pubmed: 29545365
Arterioscler Thromb Vasc Biol. 2021 Dec;41(12):2890-2905
pubmed: 34587758
Circ Res. 2014 Jun 6;114(12):1852-66
pubmed: 24902970
Circulation. 2020 Nov 24;142(21):2060-2075
pubmed: 32962412
Circulation. 2020 Sep 29;142(13):1279-1293
pubmed: 32703007
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Front Immunol. 2020 Sep 10;11:2175
pubmed: 33013913
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045-51
pubmed: 22895665
J Card Surg. 2020 Jun;35(6):1314-1321
pubmed: 32353909
Methods. 2021 Mar;187:44-53
pubmed: 32240773
Arch Dis Child Educ Pract Ed. 2013 Dec;98(6):236-8
pubmed: 23986538
Exp Mol Med. 2021 Sep;53(9):1379-1389
pubmed: 34548614
Immunometabolism. 2021;3(3):
pubmed: 34178388
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Int J Mol Sci. 2022 Feb 04;23(3):
pubmed: 35163719
Front Cardiovasc Med. 2021 Dec 06;8:766613
pubmed: 34938784
Stem Cell Reports. 2017 Aug 8;9(2):681-696
pubmed: 28757161
J Clin Invest. 2017 Aug 1;127(8):2904-2915
pubmed: 28650342
Front Genet. 2019 Apr 05;10:317
pubmed: 31024627
Circ Res. 2020 Jul 17;127(3):402-426
pubmed: 32673538
Clin Transl Med. 2017 Dec;6(1):10
pubmed: 28220395
JCI Insight. 2020 Feb 13;5(3):
pubmed: 32051336
Circ Res. 2020 Nov 6;127(11):1437-1455
pubmed: 32981416
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1055-1071
pubmed: 30943771
Nat Metab. 2021 Feb;3(2):166-181
pubmed: 33619382
Circ Res. 2018 Jun 8;122(12):1675-1688
pubmed: 29545366
Cell Stem Cell. 2020 Jan 2;26(1):81-96.e4
pubmed: 31883835
EBioMedicine. 2019 Aug;46:274-289
pubmed: 31395500
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
BMC Genomics. 2012 Jul 18;13:320
pubmed: 22809019
Trends Genet. 2014 Sep;30(9):418-26
pubmed: 25108476
Exp Mol Med. 2018 Aug 7;50(8):1-14
pubmed: 30089861
Genome Biol. 2020 Feb 7;21(1):31
pubmed: 32033589
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2049-2066
pubmed: 31340667
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
Atherosclerosis. 2021 May;324:123-132
pubmed: 33714552
Circulation. 2020 Aug 11;142(6):575-590
pubmed: 32441123
Front Cardiovasc Med. 2021 Apr 20;8:655869
pubmed: 33959644
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830865
J Cell Physiol. 2020 Sep;235(9):6139-6153
pubmed: 32020590

Auteurs

Liam W McQueen (LW)

Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.

Shameem S Ladak (SS)

Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.

Riccardo Abbasciano (R)

Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.

Sarah J George (SJ)

Bristol Heart Institute and Translational Biomedical Research Centre, Bristol Medical School, Bristol Royal Infirmary, University of Bristol, Bristol, United Kingdom.

M-Saadeh Suleiman (MS)

Bristol Heart Institute and Translational Biomedical Research Centre, Bristol Medical School, Bristol Royal Infirmary, University of Bristol, Bristol, United Kingdom.

Gianni D Angelini (GD)

Bristol Heart Institute and Translational Biomedical Research Centre, Bristol Medical School, Bristol Royal Infirmary, University of Bristol, Bristol, United Kingdom.

Gavin J Murphy (GJ)

Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.

Mustafa Zakkar (M)

Department of Cardiovascular Sciences, Clinical Science Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.

Classifications MeSH